Cantitate/Preț
Produs

Pharmaceutical Medicine: Oxford Specialist Handbooks

Editat de Adrian Kilcoyne, Phil Ambery, Daniel O'Connor
en Limba Engleză Flexibound – 22 mai 2013
The breadth of the pharmaceutical medicine can be daunting, but this book is designed to navigate a path through the speciality. Providing a broad overview of all topics relevant to the discipline of pharmaceutical medicine, it gives you the facts fast, in a user-friendly format, without having to dive through page upon page of dense text.With 136 chapters spread across 8 sections, the text offers a thorough grounding in issues ranging from medicines regulation to clinical trial design and data management. This makes it a useful revision aid for exams as well as giving you a taster of areas of pharmaceutical medicine adjacent to your current role. For healthcare professionals already working in the field, this book offers a guiding hand in difficult situations as well as supplying rapid access to the latest recommendations and guidelines.Written by authors with experience in the industry and drug regulation, this comprehensive and authoritative guide provides a shoulder to lean on throughout your pharmaceutical career.
Citește tot Restrânge

Din seria Oxford Specialist Handbooks

Preț: 35573 lei

Preț vechi: 51920 lei
-31% Nou

Puncte Express: 534

Preț estimativ în valută:
6808 7072$ 5655£

Carte tipărită la comandă

Livrare economică 22-28 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780199609147
ISBN-10: 0199609144
Pagini: 480
Ilustrații: 30 black and white images
Dimensiuni: 101 x 181 x 18 mm
Greutate: 0.37 kg
Editura: Oxford University Press
Colecția OUP Oxford
Seria Oxford Specialist Handbooks

Locul publicării:Oxford, United Kingdom

Recenzii

The way the detailed information is presented fits very well, for example, in providing answers in the format and style suggested for short answer type questions in the exams...I see it as a useful addition to my reference sources and I think others will find it useful too.

Notă biografică

Dr. Adrian Kilcoyne graduated from Trinity College Dublin in 1995. Following time as a Registrar in Reproductive Medicine in London, he spent some time as a Specialist Registrar in Public Health Medicine in Oxford followed by some years as a GP. He completed a Masters in Public Health at the London School of Hygiene and Tropical Medicine and a Masters in Business Administration at Warwick Business School. He joined the pharmaceutical industry in 2006 to become a Senior Clinical Research Physician in Diabetes at Eli Lilly. He has since held Medical Director positions at Baxter Healthcare and Roche and is now Medical Director at Sanofi Pasteur MSD, a dedicated vaccine company. Adrian has completed the Diploma in Pharmaceutical Medicine and is a Member of the Faculty of Pharmaceutical Medicine and has completed Higher medical Training in Pharmaceutical medicine. Dr. Daniel O'Connor is a Leicester medical graduate with a background in cancer research, histopathology and oncology. He joined the Medicines and Healthcare products Regulatory Agency (MHRA) as a Medical Assessor in 2006 from a clinical lecturer post at UCL/UCH/Ludwig Institute for Cancer Research. He works in the licensing division of the MHRA, mainly reviewing oncology products and is also the UK representative on the Committee for Orphan Medicinal Products (COMP). He completed specialist training in Pharmaceutical Medicine in 2012. He is a fellow of the Foulkes Foundation.Dr. Phil Ambery qualified in medicine from the University of Bristol in 1994. He undertook registrar training in the South-West of England and in Sydney, before returning to the UK in 2000 to study diabetes and endocrinology before leaving the NHS to work for GlaxoSmithKline. Since then he has held various posts in the GSK commercial organisation and latterly as a clinical program leader in the metabolic and cardiovascular pathways group at Glaxo. He is also an honorary clinical fellow at Addenbrooke's Hospital Cambridge, and a GMC specialist partner. He has a number of publications in the field of diabetes and cardiovascular medicine, and on the MRCP examination.